Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 12 5 2020
Statut: ppublish

Résumé

The aim of this study was to develop evidence-based recommendations for safe, effective and appropriate thyroidectomy. Surgical management of thyroid disease has evolved considerably over several decades leading to variability in rendered care. Over 100,000 thyroid operations are performed annually in the United States. The medical literature from January 1, 1985 to November 9, 2018 was reviewed by a panel of 19 experts in thyroid disorders representing multiple disciplines. The authors used the best available evidence to construct surgical management recommendations. Levels of evidence were determined using the American College of Physicians grading system, and management recommendations were discussed to consensus. Members of the American Association of Endocrine Surgeons reviewed and commented on preliminary drafts of the content. These clinical guidelines analyze the indications for thyroidectomy as well as its definitions, technique, morbidity, and outcomes. Specific topics include Pathogenesis and Epidemiology, Initial Evaluation, Imaging, Fine Needle Aspiration Biopsy Diagnosis, Molecular Testing, Indications, Extent and Outcomes of Surgery, Preoperative Care, Initial Thyroidectomy, Perioperative Tissue Diagnosis, Nodal Dissection, Concurrent Parathyroidectomy, Hyperthyroid Conditions, Goiter, Adjuncts and Approaches Laryngology Familial Thyroid Cancer, Postoperative Care and Complications, Cancer Management, and Reoperation. Evidence-based guidelines were created to assist clinicians in the optimal surgical management of thyroid disease.

Sections du résumé

OBJECTIVE
The aim of this study was to develop evidence-based recommendations for safe, effective and appropriate thyroidectomy.
BACKGROUND
Surgical management of thyroid disease has evolved considerably over several decades leading to variability in rendered care. Over 100,000 thyroid operations are performed annually in the United States.
METHODS
The medical literature from January 1, 1985 to November 9, 2018 was reviewed by a panel of 19 experts in thyroid disorders representing multiple disciplines. The authors used the best available evidence to construct surgical management recommendations. Levels of evidence were determined using the American College of Physicians grading system, and management recommendations were discussed to consensus. Members of the American Association of Endocrine Surgeons reviewed and commented on preliminary drafts of the content.
RESULTS
These clinical guidelines analyze the indications for thyroidectomy as well as its definitions, technique, morbidity, and outcomes. Specific topics include Pathogenesis and Epidemiology, Initial Evaluation, Imaging, Fine Needle Aspiration Biopsy Diagnosis, Molecular Testing, Indications, Extent and Outcomes of Surgery, Preoperative Care, Initial Thyroidectomy, Perioperative Tissue Diagnosis, Nodal Dissection, Concurrent Parathyroidectomy, Hyperthyroid Conditions, Goiter, Adjuncts and Approaches Laryngology Familial Thyroid Cancer, Postoperative Care and Complications, Cancer Management, and Reoperation.
CONCLUSION
Evidence-based guidelines were created to assist clinicians in the optimal surgical management of thyroid disease.

Identifiants

pubmed: 32079828
doi: 10.1097/SLA.0000000000003735
pii: 00000658-202003000-00001
doi:

Types de publication

Journal Article Practice Guideline Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-410

Commentaires et corrections

Type : CommentIn

Auteurs

Kepal N Patel (KN)

Division of Endocrine Surgery, NYU Langone Health, New York, NY.

Linwah Yip (L)

Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Carrie C Lubitz (CC)

Department of Surgery, Massachusetts General Hospital, Boston, MA.

Elizabeth G Grubbs (EG)

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.

Barbra S Miller (BS)

Division of Endocrine Surgery, University of Michigan, Ann Arbor, MI.

Wen Shen (W)

Department of Surgery, University of California San Francisco, San Francisco, CA.

Peter Angelos (P)

Department of Surgery and MacLean Center for Clinical Medical Ethics, The University of Chicago, Chicago, IL.

Herbert Chen (H)

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.

Gerard M Doherty (GM)

Department of Surgery, Brigham and Women's Hospital, Boston, MA.

Thomas J Fahey (TJ)

Department of Surgery, The New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY.

Electron Kebebew (E)

Department of Surgery and Stanford Cancer Institute, Stanford University, Stanford, CA.

Virginia A Livolsi (VA)

Department of Pathology and Laboratory Medicine, Perelman School of Medicine of University of Pennsylvania, Philadelphia, PA.

Nancy D Perrier (ND)

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.

Jennifer A Sipos (JA)

Division of Endocrinology and Metabolism, The Ohio State University, Columbus, OH.

Julie A Sosa (JA)

Department of Surgery, University of California San Francisco, San Francisco, CA.

David Steward (D)

Department of Otolaryngology, University of Cincinnati College of Medicine, Cincinnati, OH.

Ralph P Tufano (RP)

Division of Head and Neck Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins School of Medicine, Baltimore, MD.

Christopher R McHenry (CR)

MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Sally E Carty (SE)

Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH